1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: EORTC-30944
|
|
2.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-GU-30986, NCT00014274
|
|
3.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-75100
|
|
4.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1583
|
|
5.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: MDA-MBDT-8085
|
|
6.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8107
|
|
7.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 55
Sponsor:
Protocol IDs: UCLA-81107522, NCI-V83-0180
|
|
8.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor: NCI
Protocol IDs: MSKCC-87102, NCI-T87-0235C, T87-0235
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: HOG-GU93-1, NCI-V94-0424
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: Other
Protocol IDs: CAN-NCIC-HD6, E-JHD06, NCI-V94-0427, NCT00002561, HD6, JHD06
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 69
Sponsor:
Protocol IDs: CRC-TU-HO3001, EU-93029
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor:
Protocol IDs: FRE-IT94, FRE-FNCLCC-IT94, NCI-F94-0019, NCT00002566
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9410, RTOG-94-10
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21 at diagnosis
Sponsor: NCI
Protocol IDs: CCG-5942
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-MBDT-8008
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-LU20, EU-95041
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-75104
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: FRE-IALT, EU-96010, NCT00002823
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MDA-DM-95231, NCI-G96-1044, NCT00002855
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 10 to 70
Sponsor: NCI
Protocol IDs: MDA-ID-95196, MDA-DM-95196, NCI-G96-1089, NCT00002882
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-E3695, CLB-509802, SWOG-E3695, NCT00003027, E3695
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: MRC-LU22, EORTC-08012, EU-97016, ISRCTN25582437, NCT00003159
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: EORTC-55954, MRC-CE04, COSA, EU-98061, NSGO-CC-9502, NCT00003209
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Adult
Sponsor:
Protocol IDs: LLCG-BLT, MRC-BLT, EU-98003, NCT00003240
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-4897, CLB-99908, GUMC-01011, NCT00003376, E4897
|
